Schaefer has since met up with his son Harold in Mexico City, who joined him for the next leg of his ride back to Canada. I caught up with Schaefer on the northern coast of South America in French Guyana, just as Wellwood was preparing to head home after three and half years and more than 45,000 kilometres.
Neither was ready to end their journey and both wanted to continue minimizing their carbon footprint. But once they arrived, they turned their bikes back north and started riding up the east coast of Argentina. Their original goal was to ride to Ushuaia, the end of the road on mainland South America. Fulfilling a dream, they spent over a year traversing the Andean region, mostly travelling remote roads through towns and villages off the beaten path. From Atlantic Canada, they headed south down the east coast, into Mexico and through Central America, where they took a sailboat from Panama to Cartagena, Colombia. They started with a cross-Canada journey to see if they actually liked travelling by bicycle (they did). Lothar Schaefer, a retired anesthesiologist, and his partner Debbie Wellwood, a wildlife ecologist, rode out of their small town in northwest British Columbia on recumbent bikes in June 2015, with Schaefer thinking they’d be gone anywhere from two to five years. Photos courtesy Debbie Wellwood and Lothar Schaefer. To read this article on click here.Lothar Schaefer rides into Rio de Janeiro in August.
Slomo ride download#
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.īe sure to follow all of these stock-moving metrics, and many more, on. The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. This group has a Zacks Industry Rank of 213, putting it in the bottom 17% of all 250+ industries.
The Medical - Biomedical and Genetics industry is part of the Medical sector. Medical - Biomedical and Genetics stocks are, on average, holding a PEG ratio of 1.38 based on yesterday's closing prices. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. We can also see that MRNA currently has a PEG ratio of 0.68. Its industry sports an average Forward P/E of 24.39, so we one might conclude that MRNA is trading at a discount comparatively. Valuation is also important, so investors should note that MRNA has a Forward P/E ratio of 8.16 right now. MRNA is currently sporting a Zacks Rank of #3 (Hold). Within the past 30 days, our consensus EPS projection remained stagnant. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Our system takes these estimate changes into account and delivers a clear, actionable rating model. We developed the Zacks Rank to capitalize on this phenomenon.
As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.īased on our research, we believe these estimate revisions are directly related to near-team stock moves. These revisions help to show the ever-changing nature of near-term business trends. Investors might also notice recent changes to analyst estimates for MRNA.
0 kommentar(er)
